Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,678,290
-
Share change
-
-1,228,637
-
Total reported value
-
$16,431,363
-
Price per share
-
$2.14
-
Number of holders
-
35
-
Value change
-
-$2,174,943
-
Number of buys
-
13
-
Number of sells
-
19
Institutional Holders of MILLENDO THERAPEUTICS INC - COM (MLND) as of Q4 2020
As of 31 Dec 2020,
MILLENDO THERAPEUTICS INC - COM (MLND) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,678,290 shares.
The largest 10 holders included
NEA Management Company, LLC, COMMODORE CAPITAL LP, Ghost Tree Capital, LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, BARCLAYS PLC, Anson Funds Management LP, VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.